NewGenIvf (NIVF) Convertible Debt (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Convertible Debt of $4.1 million for Q4 2025, up 75.93% year-over-year from $2.3 million in Q4 2024, and down 100.0% quarter-over-quarter from $4900.0 billion in Q3 2025.
NewGenIvf (NIVF) Convertible Debt (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Convertible Debt for 2 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Convertible Debt rose 75.93% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $4.1 million (up 75.93% YoY), while the FY2025 annual figure was $4.1 million, up 75.93% from the prior year.
- Convertible Debt fell to $4.1 million in Q4 2025 per NIVF's latest filing, from $4900.0 billion in the prior quarter.
- Across five years, Convertible Debt topped out at $4900.0 billion in Q3 2025 and bottomed at $2.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 4,900.00 Bn |
| Jun 30, 2025 | 3.43 Mn |
| Dec 31, 2024 | 2.33 Mn |